Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
In biological research, especially in areas such a
The Nobel Prize in Physiology or Medicine awarded
In today’s rapidly evolving bioprocessing landsc
By the end of 2025, the pharma, laboratory, and an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of The Magazine
Russia expects to register a second possible vaccine against COVID-19 from October 15, the TASS news agency mentioned Russian consumer security watchdog Rospotrebnadzor as saying on Tuesday.
The vaccine was developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August. Late-stage trials, involving at least 40,000 people, are continuing.
